Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Jazz Pharmaceuticals plc (JAZZ) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $131.01 Metrics
OS: 63.1 M -2 % ROE
Market cap: $8.27 B 29 % ROIC
Net debt: $4.44 B 3.8 x Debt/EBITDA
EV: $12.7 B

 
TTM Valuation
EBITDA $1.2 B 10.8 x EV/EBITDA
EBIT $569 M 22.3 x EV/EBIT
EPS ($1.80)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
Revenues3,659.43,094.22,363.62,161.81,890.91,618.71,488.01,324.8
            Revenue growth18.3%30.9%9.3%14.3%16.8%8.8%12.3%13.0%
Cost of goods sold540.5440.8148.9127.9121.5110.2105.4102.5
Gross profit3,118.92,653.52,214.72,033.81,769.41,508.51,382.61,222.3
            Gross margin85.2%85.8%93.7%94.1%93.6%93.2%92.9%92.3%
Selling, general and administrative1,417.01,451.7854.2736.9683.5544.2502.9449.1
Research and development590.5505.7335.4299.7226.6198.4162.3135.3
EBITA1,121.4696.81,028.01,001.3861.4766.9693.3637.9
            EBITA margin30.6%22.5%43.5%46.3%45.6%47.4%46.6%48.2%
Amortization of intangibles599.2525.8259.6354.8201.5152.1102.098.2
EBIT522.2171.0768.4646.4659.9614.9591.3539.7
            EBIT margin14.3%5.5%32.5%29.9%34.9%38.0%39.7%40.7%
Pre-tax income-372.8-112.8275.1454.3529.5441.1532.4435.9
Income taxes-158.6216.133.5-73.280.2-47.7135.2106.4
            Tax rate42.6% 12.2% 15.1% 25.4%24.4%
Net income-224.1-329.7238.6523.4447.1487.8396.8329.5
            Net margin-6.1%-10.7%10.1%24.2%23.6%30.1%26.7%24.9%
 
Diluted EPS($3.58)($5.52)$4.22$9.09$7.30$7.96$6.41$5.23
Shares outstanding (diluted)62.559.756.557.661.261.361.963.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy